Comment on

• Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention.

  Solomon SD, McMurray JJ, Pfeffer MA, Wittes J, Fowler R, Finn P, Anderson WF, Zauber A, Hawk E, Bertagnolli M; Adenoma Prevention with Celecoxib (APC) Study Investigators. Solomon SD, et al. N Engl J Med. 2005 Mar 17;352(11):1071-80. doi: 10.1056/NEJMoa050405. Epub 2005 Feb 15. N Engl J Med. 2005. PMID: 15713944 Clinical Trial.
• COX-2 inhibitors--lessons in drug safety.

  Psaty BM, Furberg CD. Psaty BM, et al. N Engl J Med. 2005 Mar 17;352(11):1133-5. doi: 10.1056/NEJMe058042. Epub 2005 Feb 15. N Engl J Med. 2005. PMID: 15713946 No abstract available.
• COX-2 inhibitors--a lesson in unexpected problems.

  Drazen JM. Drazen JM. N Engl J Med. 2005 Mar 17;352(11):1131-2. doi: 10.1056/NEJMe058038. Epub 2005 Feb 15. N Engl J Med. 2005. PMID: 15713947 No abstract available.